Understanding innate immunity in fungi
了解真菌的先天免疫
基本信息
- 批准号:10218397
- 负责人:
- 金额:$ 23.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsAnti-Bacterial AgentsApoptosisBacteriaBacterial InfectionsBiological ModelsCell DeathCell WallCell physiologyCellsChromosome MappingClinicalDataDiseaseEnvironmentEvolutionFoundationsFungi ModelFutureGenesGenetic ScreeningGenomicsGoalsHealthHumanImmuneImmunotherapeutic agentIncidenceIndividualInfectionInvadedKnowledgeMetabolismMicrobeModificationMolecularMucorMucormycosisMycosesNatural ImmunityOrganismOutcomePatientsPerceptionPharmacologyPlantsProcessRNA InterferenceReactionReactive Oxygen SpeciesReproductionResistanceRespiratory BurstRoleSignal TransductionSystemTestingTherapeuticWorkWound Infectionantimicrobialantimicrobial drugbasedefense responsefungusgene functioninsightmortalitymutantmutualismnovelopportunistic pathogenplant fungipreventprogramsresponsesensorsmall moleculetargeted treatmenttooltraumatic woundtreatment strategy
项目摘要
PROJECT SUMMARY
The goal of this exploratory work is to develop foundations for understanding innate immunity defenses in
Mucoromycotina fungi, with a particular focus on the mechanisms triggering programmed cell death (PCD).
We expect that these processes will become future targets for controlling mucormycoses, which are human
infections caused by Mucoromycotina. Mucormycoses are increasingly frequent, highly destructive, and often
fatal in immune-compromised individuals.
Some clinical isolates of Mucoromycotina harbor endosymbiotic bacteria (EB) that can be isolated and
cultivated independently. Our recent work generated insights into fungal responses to such isolated EB that
were perceived by fungi as mutualists versus antagonists. In mutualisms, bacteria enter fungal cells and
manipulate cellular processes of permissive hosts. In antagonisms, bacterial infections of non-host fungi are
blocked by fungal responses that resemble innate immunity of animals and plants. In animals and plants,
innate immunity mechanisms prevent bacterial invasions of cellular environment and suppress those invasions
by initiating PCD.
To accomplish our goal of unraveling novel mechanisms of innate immunity in Mucoromycotina, we will use
isolated EB as a tool to elicit fungal defense responses. We will test whether Mucoromycotina are able to: (i)
sense microbes, (iii) deploy defense modules that prevent bacterial entry, and (iii) when faced with bacteria
capable of breaching these primary defenses, trigger PCD to eliminates intruders. To test these hypotheses,
we will address the following specific aims: (1) determine the roles of candidate innate immunity sensors in
bacterial infection of non-host strains and (2) identify novel genes responsible for elimination of bacterial
infections, including genes that control defense and PCD modules.
In addition to their profound health impacts, Mucoromycotina present a remarkably convenient study system
for elucidating fungal-bacterial interactions in polymicrobial disorders. Expected outcomes of the project
include determination of the molecular bases of fungal innate immunity and PCD, which, in the future, could be
targeted to eradicate Mucoromycotina infections.
项目概要
这项探索性工作的目标是为理解先天免疫防御奠定基础
毛霉菌亚门真菌,特别关注触发程序性细胞死亡(PCD)的机制。
我们预计这些过程将成为控制人类毛霉菌病的未来目标
由毛霉菌亚门引起的感染。毛霉菌病越来越频繁,具有高度破坏性,并且经常
对于免疫功能低下的个体来说是致命的。
毛霉菌门的一些临床分离株含有内共生细菌 (EB),可以将其分离和
独立培养。我们最近的工作深入了解了真菌对这种孤立的 EB 的反应,
被真菌视为互利共生者与拮抗者。在互利共生中,细菌进入真菌细胞并
操纵许可宿主的细胞过程。在拮抗作用中,非宿主真菌的细菌感染是
被类似于动植物先天免疫的真菌反应所阻断。在动物和植物中,
先天免疫机制防止细菌入侵细胞环境并抑制这些入侵
通过启动PCD。
为了实现我们揭示毛霉菌先天免疫新机制的目标,我们将使用
分离的 EB 作为引发真菌防御反应的工具。我们将测试毛霉菌亚门是否能够:(i)
感知微生物,(iii) 部署防御模块以防止细菌进入,以及 (iii) 面对细菌时
能够突破这些主要防御,触发 PCD 消灭入侵者。为了检验这些假设,
我们将实现以下具体目标:(1)确定候选先天免疫传感器在
非宿主菌株的细菌感染和(2)鉴定负责消除细菌的新基因
感染,包括控制防御和 PCD 模块的基因。
除了对健康产生深远的影响外,毛霉菌亚门还提供了一个非常方便的研究系统
用于阐明多种微生物疾病中真菌-细菌的相互作用。项目预期成果
包括确定真菌先天免疫和 PCD 的分子基础,这在未来可能是
旨在根除毛霉菌感染。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa E Pawlowska其他文献
Teresa E Pawlowska的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa E Pawlowska', 18)}}的其他基金
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
Fosl2调控染色质开放性在哺乳动物卵丘-卵母细胞复合物成熟过程中的机制研究
- 批准号:82301863
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
H5亚型禽流感病毒PA蛋白诱导降解JAK1增强病毒对哺乳动物致病性的作用及机制研究
- 批准号:32373042
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
动物双歧杆菌对不同聚合度低聚木糖同化差异性的分子机制研究
- 批准号:32302789
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于扁颅蝠类群系统解析哺乳动物脑容量适应性减小的演化机制
- 批准号:32330014
- 批准年份:2023
- 资助金额:215 万元
- 项目类别:重点项目
相似海外基金
Developing Therapeutic Gel Embolic Agents for Arteriovenous Malformation Embolization
开发用于动静脉畸形栓塞治疗的凝胶栓塞剂
- 批准号:
10667726 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
- 批准号:
10674131 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Bionanomatrix coating to enhance antibacterial effects while reducing inflammation of knee joint implants
生物纳米基质涂层可增强抗菌效果,同时减少膝关节植入物的炎症
- 批准号:
10822220 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Electrochemical Catheter for Prevention of Central Line-Associated Bloodstream Infection
用于预防中心静脉导管相关血流感染的电化学导管
- 批准号:
10560927 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别:
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 23.55万 - 项目类别: